Marfan syndrome

Background

  • Marfan syndrome (MFS) is a heritable connective tissue disorder with multi-system involvement
    • First described by Antoine Marfan in 1896
    • Clinical features vary along a spectrum typical of autosomal-dominant disorders
  • Autosomal-dominant mutation in FBN1 gene (encoding fibrillin-1) on chromosome 15
    • This results in cystic medial degeneration of the aortic tunica media (leading to increased risk of aortic aneurysm / dissection)
    • This also interferes with elastin deposition during extracellular matrix formation implicates in the elasticity of multiple tissue types
    • Majority of cases (75%) are familial / inherited vs. minority (25%) are de novo mutations
  • Estimated prevalence of 1/5000 individuals worldwide (equal between men and women)
  • Life expectancy for those diagnosed and treated is now close to that of non-MFS population (previously expected increase in patient mortality by third and fourth decades of life)

Clinical Features (not all may be present)

  • Tall stature, long extremities
  • Reduce upper-to-lower segment ratio, increased arm span-to-height ratio
  • Arachnodactyly (“wrist sign, thumb sign), reduced elbow extension
  • Scoliosis or thoracolumbar kyphosis
  • Pectus excavatum or carinatum
  • Ligamentous laxity, hyperextensibility
  • Protrusio acetabuli
  • Hindfoot deformity, plain flat foot
  • Ectopia lentis
  • Myopia (often severe); retinal detachment
  • Lumbrosacral dural ectasia
  • Dolichocephaly, downward slanting palpebral fissures, enophthalmos, retrognathia, malar hypoplasia, high arched palate
  • Skin striae

Increased risk of: